[{"address1": "830 Winter Street", "city": "Waltham", "state": "MA", "zip": "02451", "country": "United States", "phone": "857 399 9500", "website": "https://www.tscan.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "TScan Therapeutics, Inc., a clinical-stage biotechnology company, develops T cell receptor-engineered T cell (TCR-T) therapies for the treatment of patients with cancer in the United States. The company's lead product candidates include TSC-100 and TSC-101 for the treatment of patients with acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), and acute lymphoblastic leukemia (ALL) in patients undergoing allogeneic hematopoietic cell transplantation (HCT) is in Phase I clinical trial, as well as eliminates residual disease and promotes donor chimerism. It also advanced TS-102 into IND-enabling activities. In addition, the company develops TSC-200, TSC-201, TSC-202, TSC-203, and TSC-204, which are in Phase 1 clinical trial, for the treatment of solid tumors. It has collaboration agreements with Novartis Institutes for BioMedical Research, Inc. to discover and develop novel TCR-T therapies; and Amgen Inc. to identify antigens recognized by T cells in patients with Crohn's disease using TargetScan, a proprietary target discovery platform. TScan Therapeutics, Inc. was incorporated in 2018 and is headquartered in Waltham, Massachusetts.", "fullTimeEmployees": 208, "companyOfficers": [{"maxAge": 1, "name": "Dr. Gavin  MacBeath Ph.D.", "age": 54, "title": "CEO & Director", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 1025727, "exercisedValue": 0, "unexercisedValue": 207573}, {"maxAge": 1, "name": "Mr. Jason A. Amello CPA", "age": 56, "title": "CFO & Treasurer", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 767342, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Chrystal U. Louis M.D., M.P.H.", "age": 48, "title": "Chief Medical Officer", "yearBorn": 1976, "fiscalYear": 2024, "totalPay": 550125, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stephen J. Elledge Ph.D.", "title": "Co-Founder & Chairman of Scientific Advisory Board", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Tomasz  Kula Ph.D.", "title": "Co-Founder & Member of Advisory Board", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Justin  McCue Ph.D.", "title": "Chief Technology Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Zoran  Zdraveski J.D., Ph.D.", "age": 54, "title": "Chief Legal & Strategy Officer and Company Secretary", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 657200, "exercisedValue": 0, "unexercisedValue": 85247}, {"maxAge": 1, "name": "Ms. Ann  Hargraves", "title": "Senior Vice President of Human Resources", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Shrikanta  Chattopadhyay M.D.", "title": "Senior VP & Head of Translational Medicine", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ray  Lockard M.B.A.", "title": "Senior Vice President & Head of Quality", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 6, "compensationRisk": 8, "shareHolderRightsRisk": 10, "overallRisk": 9, "governanceEpochDate": 1754006400, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.74, "open": 1.75, "dayLow": 1.75, "dayHigh": 1.89, "regularMarketPreviousClose": 1.74, "regularMarketOpen": 1.75, "regularMarketDayLow": 1.75, "regularMarketDayHigh": 1.89, "payoutRatio": 0.0, "beta": 0.992, "forwardPE": -1.4496125, "volume": 351750, "regularMarketVolume": 351750, "averageVolume": 426269, "averageVolume10days": 228820, "averageDailyVolume10Day": 228820, "bid": 1.84, "ask": 1.91, "bidSize": 1, "askSize": 1, "marketCap": 106118760, "fiftyTwoWeekLow": 1.02, "fiftyTwoWeekHigh": 6.225, "priceToSalesTrailing12Months": 15.244758, "fiftyDayAverage": 1.6898, "twoHundredDayAverage": 2.254075, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -15226253, "profitMargins": 0.0, "floatShares": 44031335, "sharesOutstanding": 52471400, "sharesShort": 1717845, "sharesShortPriorMonth": 1978866, "sharesShortPreviousMonthDate": 1751241600, "dateShortInterest": 1753920000, "sharesPercentSharesOut": 0.0304, "heldPercentInsiders": 0.00228, "heldPercentInstitutions": 0.79407, "shortRatio": 5.32, "shortPercentOfFloat": 0.0369, "impliedSharesOutstanding": 5143130, "bookValue": 3.114, "priceToBook": 0.6005138, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -136775008, "trailingEps": -1.1, "forwardEps": -1.29, "enterpriseToRevenue": -2.187, "enterpriseToEbitda": 0.108, "52WeekChange": -0.67019403, "SandP52WeekChange": 0.1513431, "quoteType": "EQUITY", "currentPrice": 1.87, "targetHighPrice": 12.0, "targetLowPrice": 3.0, "targetMeanPrice": 8.57143, "targetMedianPrice": 9.0, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 7, "totalCash": 218044992, "totalCashPerShare": 3.842, "ebitda": -141123008, "totalDebt": 96700000, "quickRatio": 6.961, "currentRatio": 7.06, "totalRevenue": 6961000, "debtToEquity": 54.721, "revenuePerShare": 0.123, "returnOnAssets": -0.26773, "returnOnEquity": -0.63331, "grossProfits": -8573000, "freeCashflow": -83615872, "operatingCashflow": -126183000, "revenueGrowth": 4.739, "grossMargins": -1.23158, "ebitdaMargins": 0.0, "operatingMargins": -12.56599, "financialCurrency": "USD", "symbol": "TCRX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "postMarketTime": 1755893484, "regularMarketTime": 1755892800, "exchange": "NGM", "messageBoardId": "finmb_583057578", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "postMarketChangePercent": 2.144384, "postMarketPrice": 1.9101, "postMarketChange": 0.04009998, "regularMarketChange": 0.13, "regularMarketDayRange": "1.75 - 1.89", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 426269, "fiftyTwoWeekLowChange": 0.85, "fiftyTwoWeekLowChangePercent": 0.8333334, "fiftyTwoWeekRange": "1.02 - 6.225", "fiftyTwoWeekHighChange": -4.355, "fiftyTwoWeekHighChangePercent": -0.69959843, "fiftyTwoWeekChangePercent": -67.0194, "earningsTimestamp": 1755144000, "earningsTimestampStart": 1762950600, "earningsTimestampEnd": 1762950600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.1, "epsForward": -1.29, "epsCurrentYear": -1.24957, "priceEpsCurrentYear": -1.4965148, "fiftyDayAverageChange": 0.18019998, "fiftyDayAverageChangePercent": 0.106639825, "twoHundredDayAverageChange": -0.38407505, "twoHundredDayAverageChangePercent": -0.17039143, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-07-16", "averageAnalystRating": "1.5 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1626442200000, "regularMarketChangePercent": 7.47126, "regularMarketPrice": 1.87, "corporateActions": [], "shortName": "TScan Therapeutics, Inc.", "longName": "TScan Therapeutics, Inc.", "displayName": "TScan Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-08-23"}]